Angiotensin II type 2 receptor mediates high fat diet-induced cardiomyocyte hypertrophy and hypercholesterolemia (2019)
- Authors:
- USP affiliated authors: DONATO JÚNIOR, JOSÉ - ICB ; CHAVES, MARIA LUIZA MORAIS BARRETO DE - ICB ; DINIZ, GABRIELA PLACONÁ - ICB ; FONSECA, RENATA INZINNA BERNARDO - ICB ; LIMA, VANESSA MORAIS - ICB ; LINO, CAROLINE ANTUNES - ICB ; SILVA, TÁBATHA DE OLIVEIRA - ICB
- Unidade: ICB
- DOI: 10.1016/j.mce.2019.110576
- Subjects: ANATOMIA; FISIOLOGIA; ANGIOTENSINA II; METABOLISMO; OBESIDADE; GLICOSE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Molecular and Cellular Endocrinology
- ISSN: 1872-8057
- Volume/Número/Paginação/Ano: v. 498, p. 1-10, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LIMA, Vanessa Morais et al. Angiotensin II type 2 receptor mediates high fat diet-induced cardiomyocyte hypertrophy and hypercholesterolemia. Molecular and Cellular Endocrinology, v. 498, p. 1-10, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.mce.2019.110576. Acesso em: 24 abr. 2024. -
APA
Lima, V. M., Lino, C. A., Senger, N., Silva, T. de O., Fonseca, R. I. B., Bader, M., et al. (2019). Angiotensin II type 2 receptor mediates high fat diet-induced cardiomyocyte hypertrophy and hypercholesterolemia. Molecular and Cellular Endocrinology, 498, 1-10. doi:10.1016/j.mce.2019.110576 -
NLM
Lima VM, Lino CA, Senger N, Silva T de O, Fonseca RIB, Bader M, Santos RAS, Donato Junior J, Barreto-Chaves MLM, Diniz GP. Angiotensin II type 2 receptor mediates high fat diet-induced cardiomyocyte hypertrophy and hypercholesterolemia [Internet]. Molecular and Cellular Endocrinology. 2019 ; 498 1-10.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.mce.2019.110576 -
Vancouver
Lima VM, Lino CA, Senger N, Silva T de O, Fonseca RIB, Bader M, Santos RAS, Donato Junior J, Barreto-Chaves MLM, Diniz GP. Angiotensin II type 2 receptor mediates high fat diet-induced cardiomyocyte hypertrophy and hypercholesterolemia [Internet]. Molecular and Cellular Endocrinology. 2019 ; 498 1-10.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.mce.2019.110576 - Ablation of miRNA-22 protects against obesity-induced adipocyte senescence and ameliorates metabolic disorders in middle-aged mice
- Set7 deletion prevents glucose intolerance and improves the recovery of cardiac function after ischemia and reperfusion in obese female mice
- Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy
- Deletion of miRNA-22 induces cardiac hypertrophy in females but attenuates obesogenic diet-mediated metabolic disorders
- The miRNA-143-3p-Sox6-Myh7 pathway is altered in obesogenic diet-induced cardiac hypertrophy
- Beta‐arrestin 2 mediates cardiac hypertrophy induced by thyroid hormones via AT1R
- Beta-arrestins in the context of cardiovascular diseases: focusing on angiotensin II type 1 receptor (AT1R)
- AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth
- MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone
- Ubiquitin proteasome system (UPS) activation in the cardiac hypertrophy ofhyperthyroidism
Informações sobre o DOI: 10.1016/j.mce.2019.110576 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
